WELL Health.ai develops and invests in AI-enabled tools and technologies for healthcare providers, aiming to positively impact health outcomes.

WELL Health.ai

WELL Health.ai develops and invests in AI-enabled tools and technologies for healthcare providers, focusing on improving health outcomes and efficiently integrating artificial intelligence into healthcare practices.

WELL Health Technologies Corp. (TSX: WELL) | 29,786 followers on LinkedIn. WELL aims to positively impact health outcomes by leveraging technology to empower and support patients and doctors. | WELL Health is a healthcare technology company empowering providers across North America with innovative digital tools and services.  

WELL Health’s Practitioner Enablement Platform offers virtual care and digital patient engagement capabilities, along with Electronic Medical Records (EMR), Revenue Cycle Management, and cybersecurity &amp; data protection services. By reducing manual administration tasks, WELL Health helps physicians and healthcare providers increase time spent with patients and avoid burnout.

VP Product | Coach, Advisor, Leadership roles, Technology expertise

Frank Seiferth

COO @ Wisp | GM, U.S. Virtual Patient Services at WELL Health

Shervin B.

Fractional CMO | B2B Technology | Product Marketing | Communications | Diversity & Inclusion

Nikki Gore

Chief Operating Officer at WELL Health Technologies

Amir Javidan

WELL Health Technologies Corp. (TSX: WELL)

WELL continues to innovate and is pleased to announce that this past week we launched a new weight care and GLP-1 offering in Canada on our Tia Health virtual care platform. This is just the beginning as we are excited about innovating and delivering superior patient outcomes for Canadians in this category. https://ow.ly/VTzL50U2b8E

WELL has reached a significant milestone, surpassing a $1 billion annualized revenue run-rate with record Q3-2024 revenue of $251.7 million—a 27% increase over Q3-2023, driven by strong organic growth of 23%. The Company also achieved a record Adjusted EBITDA of $32.7 million in Q3-2024, marking a 16% increase compared to Q3-2023. In addition, WELL saw a record total of 1.5 million patient visits this quarter, a 41% increase from Q3-2023, putting the Company on an annualized run-rate of 5.9 million patient visits. WELL has raised its 2024 revenue guidance to $985 million to $995 million and anticipates Adjusted EBITDA to be in the upper half of $125 million to $130 million. Hamed Shahbazi , Founder and CEO of WELL, commented, "The third quarter of 2024 was one of the best quarters in the Company's history by just about every objective and important metric. In the third quarter, WELL delivered record quarterly performances for revenue, Adj EBITDA, free cashflow, patient visits and organic growth". Review WELL’s press release for details on today’s conference call and the full financial report below. https://ow.ly/w0EX50U26f5

WELL is pleased to announce that it has entered into definitive agreements to acquire the Canadian clinical assets of Jack Nathan Medical Corp. This acquisition includes both a network of 16 owned and operated primary care clinics across 13 Canadian cities and a clinic licensing business with 62 licensee clinics, which will become the model for WELL’s new Affiliate Clinic business stream. The 16 owned and operated clinics generated over $10 million in revenue in the past 12 months, while the licensing business generated over $2.2 million in annual revenue. On closing of the Transaction, WELL will acquire Jack Nathan’s rights to operate medical clinics in Walmart Canada stores, creating a platform to grow primary care operations at Walmart with the goal of expanding WELL’s owned and operated network and affiliate managed clinics within Walmart Canada’s footprint of over 400 Canadian locations. Hamed Shahbazi , Founder and CEO of WELL, commented: “Adding 90 doctors to our network and expanding with owned and affiliate clinics will enhance our ability to support physicians in delivering high-quality care. These clinics, situated in Canadian Walmart stores across a diverse network of 13 Canadian cities, will benefit from WELL’s optimization tools and digital innovations to improve efficiency and enhance the provider experience.” Learn more: https://ow.ly/V3Ov50TZr5B

Did you know the majority of age-related diseases, including cancer and heart disease, often remain undetected for years? At WELL Health Clinics , we provide Total Body Cancer and Heart Disease Screening to catch these early markers before symptoms appear. Early detection offers the potential to reverse or prevent disease progression—because your health deserves proactive care! Visit WELL Health Medical & Longevity Centres to learn how we can help. https://ow.ly/mZZ050TXhBS

Integrating mental health services into WELL Health Clinics across Canada brings significant advantages for providers: 👩⚕️ Streamlined Referrals: GPs can easily direct patients with mental health needs to specialists, reducing wait times and enhancing care coordination. 👩⚕️ Collaborative Approach: This integration allows providers to work together, focusing on their core areas of expertise and ultimately improving the quality of care and patient outcomes. 👩⚕️ Efficiency: The omni-channel model simplifies follow-ups and interdisciplinary care, making the entire process more efficient for healthcare teams. Discover more insights in our Q&A with Marion Adams , CEO of WELL Mental Health & Wellness! https://ow.ly/CHm950TWibQ

WELL Health and HEALWELL AI (TSX: AIDX) are jointly pleased to announce the expansion of a multi-year strategic alliance agreement that allows WELL and HEALWELL to launch and manage clinical trial sites at WELL clinic locations across Canada. By leveraging HEALWELL’s Contract Research Organization (CRO) capabilities alongside WELL Health’s extensive network of clinics, this partnership positions the two companies as formidable players in AI-driven clinical trials and opens up new revenue streams. Through this alliance, HEALWELL AI can offer a fully integrated service covering patient identification and recruitment, clinical trial architecture and execution, and comprehensive clinical research data analysis. Establishing clinical trial sites within WELL Health clinics transforms these locations into innovation hubs. This setup enhances accessibility for participants and directly benefits patients by bringing experimental treatments to local sites, making cutting-edge healthcare more available to the community. Dr. Michael Frankel, Chief Medical Officer of WELL, commented, “This initiative will allow WELL and HEALWELL AI to capitalize on their combined strengths in healthcare infrastructure and AI technology, potentially transforming the landscape for clinical research.” Read the full PR below: https://ow.ly/O1qH50TVoVz

WELL will release its Fiscal Third Quarter 2024 financial results for the period ending September 30, 2024, on Thursday, November 7, 2024. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 1:00 pm ET (10:00 am PT). The call will be hosted by Hamed Shahbazi , Chairman and Chief Executive Officer and Eva Fong, FCCA, CPA, CGA , Chief Financial Officer. For details on how to join the conference call, please click the link below. https://ow.ly/N3lz50TSwin

Marion Adams , CEO of WELL Mental Health & Wellness, recently shared how integrating mental health services into WELL Health Clinics across Canada reduces mental health barriers, empowering patients with key benefits: ➡️ Reduced wait times & quicker access to support ➡️ Flexible in-person & virtual service options ➡️ Streamlined access to specialized care ➡️ Personalized care plans ➡️ Physical & mental health support all in one place ➡️ A stigma-free environment encouraging seeking support ➡️ Coordination of care among healthcare providers Read the full Q&A with Marion here: https://ow.ly/3tll50TJYk3

At WELL, we are committed to transforming healthcare through innovation and collaboration. As Kevin Peesker, President, Worldwide SMB & Corporate Markets at Microsoft, emphasized, our partnership with Microsoft represents a pivotal step in this journey. This collaboration empowers us to harness the capabilities of Microsoft Azure’s robust cloud infrastructure and advanced AI technologies within WELL's digital health platforms, all while ensuring top-tier data privacy and security. This integration enhances our digital health platforms, significantly improving operational efficiency and scalability. Solutions like WELL AI Voice exemplify this collaboration by streamlining administrative tasks and alleviating the burden on healthcare professionals. Amir Javidan, COO of WELL, highlights a third-party evaluation study on the impact WELL AI Voice is making on providers, leveraging Microsoft's OpenAI service. The study found that, on average, it saves providers 3.4 minutes per encounter, translating to approximately 2 hours per day. By optimizing workflows, we enable providers to devote more time to delivering personalized, high-quality care, ultimately enhancing patient experiences. Together with Microsoft, we are not just enhancing healthcare delivery; we are building a more efficient ecosystem that meets the evolving needs of providers and patients alike. Our shared vision for a digitally transformed healthcare landscape drives us to continuously innovate, ensuring we remain at the forefront of addressing the challenges facing the industry today. Check out the video featuring WELL's executive leaders: Hamed Shahbazi , Founder, Chairman, and CEO; Eva Fong, FCCA, CPA, CGA , CFO; Shane Sabatino , CPO; and Amir Javidan , COO, as they discuss how WELL empowers providers with AI solutions.

WELL is pleased to announce the launch of a new weight care vertical by its majority-owned subsidiary, Wisp , the largest dedicated women's telehealth provider in the U.S. This expansion represents a pivotal step forward in addressing critical health needs related to hormonal imbalances and weight management for women. With this launch, Wisp offers personalized online consultations and access to four weight care solutions, including GLP-1 medications, to support women dealing with hormonal conditions such as perimenopause, menopause, Polycystic Ovary Syndrome, and endometriosis. Additionally, Wisp introduces its first-ever exclusive over-the-counter weight care capsules, designed to enhance women's metabolic health. Monica Cepak, MBA , CEO of Wisp, shares: "Wisp is committed to providing sustainable support for women's weight loss journeys, addressing a critical yet overlooked aspect of women's health—hormonal imbalances linked to perimenopause and menopause." Read's WELL's full press release: https://ow.ly/mcH450TNBIW

WELL

AI:WELLHEALTH

WELL Health.ai